bromodeoxyuridine has been researched along with Lung Neoplasms in 90 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (23.33) | 18.7374 |
| 1990's | 31 (34.44) | 18.2507 |
| 2000's | 23 (25.56) | 29.6817 |
| 2010's | 12 (13.33) | 24.3611 |
| 2020's | 3 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Knaus, EE; Mercer, JR; Wiebe, LI; Xu, LH | 1 |
| Hong, J; Kang, S; Kim, JH; Ko, SG; Kwon, YY; Moon, JH | 1 |
| Chen, X; Fu, G; Ge, M; Wang, M | 1 |
| Çetin, İ; Topçul, M | 1 |
| Fang, K; Hsieh, CH; Ni, YL; Wang, JP | 1 |
| Carrillo Garcia, C; Glassmann, A; Janzen, V; Kraus, D; Probstmeier, R; Veit, N; Winter, J | 1 |
| Moore, H; Piryatinska, A; Solis, T; Sweet-Cordero, EA; Zheng, Y | 1 |
| Shan, CJ; Wu, ZF; Xu, SZ; Zhu, SH | 1 |
| Chang, CY; Cheng, CH; Chern, JH; Chuu, JJ; Huang, CH; Huang, ZN; Li, SL; Lien, HY; Lin, CC; Wu, YY | 1 |
| Harris, CC; Pine, SR; Robles, AI; Ryan, BM; Varticovski, L | 1 |
| Hirayama, R; Kashino, G; Kinashi, Y; Liu, Y; Maruhashi, A; Masunaga, S; Matsumoto, Y; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
| Chen, L; Gao, X; Huang, CH; Huang, SL; Lu, Y; Punchard, NA; Sun, ZG; Wang, AY; Zheng, SZ | 1 |
| Jia, Q; Jiang, W; Liu, L; Ma, N; Tan, A; Zhang, H; Zhao, X | 1 |
| Kinashi, Y; Kondo, N; Liu, Y; Maruhashi, A; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Dong, QZ; Jia, HL; Li, GC; Qin, LX; Ren, N; Ye, QH | 1 |
| Kanazir, S; Konjević, G; Medić-Mijacević, L; Milosević, J; Pejanović, V; Rakić, L; Ruzdijić, S; Stokić, Z | 1 |
| Kataki, A; Marie, B; Martinet, N; Martinet, Y; Piet, M; Scheid, P; Vignaud, JM | 1 |
| Clynes, M; Meleady, P; Morley, SJ; Power, B; Walsh, D | 1 |
| Hioki, K; Hirose, M; Kodama, Y; Kurokawa, Y; Nishikawa, A; Nomura, T; Umemura, T | 1 |
| Angulo, JF; Biard, DS; Créminon, C; Despras, E; Harper, F; Miccoli, L; Pichard, E | 1 |
| Bhawe, KM; Blake, RA; Clary, DO; Flanagan, PM | 1 |
| Davis, RJ; Flavell, RA; Kennedy, NJ; Ventura, JJ | 1 |
| Alley, MC; Dasmahapatra, GP; Didolkar, P; Ghosh, S; Roy, KK; Sausville, EA | 1 |
| King, TJ; Lampe, PD | 1 |
| Bai, M; Su, Y; Zhou, Q | 1 |
| Au, JL; Lu, Z; Wientjes, TS | 1 |
| Cekanova, M; Dhar, MS; Plummer, HK; Schuller, HM | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Masegi, T; Nishikawa, A; Umemura, T | 1 |
| Chen, Y; Deutschmann, N; Pacyna-Gengelbach, M; Petersen, I; Ye, F | 1 |
| Chen, Y; Deutschmann, N; Niesporek, S; Pacyna-Gengelbach, M; Petersen, I | 1 |
| Masterson, JC; O'Dea, S | 1 |
| Arauchi, T; Nakagawa, H; Tanaka, R; Tategu, M; Yoshida, K | 1 |
| Aldovini, A; Chieco-Bianchi, L; De Rossi, A; Levis, AG; Majone, F; Montaldi, A; Ronchese, F | 1 |
| Castillo, MA; Rieber, M | 1 |
| Blijham, GH; Lenders, MH; Ramaekers, FC; Schutte, B; ten Velde, GP; Tinnemans, MM; Wagenaar, SS | 1 |
| Siegfried, JM; Singh-Kaw, P; Zarnegar, R | 1 |
| Blijham, GH; Lenders, MH; Ramaekers, FC; Schutte, B; ten Velde, GP; Tinnemans, MM | 2 |
| Bleehen, NM; Falk, SJ; Gottlieb, T; Osborne, RJ; Smith, PJ; Souès, S; Watson, JV | 1 |
| Baggs, RB; Cherian, MG; Oberdörster, G | 1 |
| Garin-Chesa, P; Lloveras, B; Melamed, M; Myc, A | 1 |
| Fukayama, M; Hayashi, Y; Ikeda, T; Kaseda, S; Koike, M; Yokoyama, T | 1 |
| Inai, K; Kawano, R; Takeshima, Y | 1 |
| Biesaga, B; Gasińska, A; Kołodziejski, L; Słonina, D | 1 |
| Biesaga, B; Gasińska, A; Kolodziejski, L | 1 |
| Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M | 1 |
| Baggs, RB; Ferin, J; Oberdörster, G | 1 |
| Bondoc, F; Ding, W; Kim, S; Liao, J; Liu, Z; Seril, DN; Yang, CS; Yang, GY | 1 |
| Bergamo, A; Capozzi, I; Clerici, K; Cocchietto, M; Salerno, G; Sava, G | 1 |
| Hayashi, H; Ito, T; Kanisawa, M; Kitamura, H; Mitui, H; Okudela, K; Udaka, N | 1 |
| Clynes, M; Daly, N; McBride, S; Meleady, P; Walsh, D | 1 |
| Ascari, E; Brugnatelli, S; Comolli, G; Danova, M; Ferrari, S; Porta, C; Pugliese, P; Riccardi, A | 1 |
| Angulo, JF; Kannouche, P | 1 |
| Anisimov, VN; Imianitov, EN; Togo, AV | 1 |
| Hong, WK; Lotan, R; Wan, H | 1 |
| Booth, E; Carnelley, T; Le, XC; Lee, J; Watson, WP; Weinfeld, M; Xing, JZ | 1 |
| Clynes, M; Meleady, P | 2 |
| Inoue, S | 1 |
| Fisher, GH; Klimstra, D; Koretsky, A; Lenczowski, JM; Lizak, MJ; Tichelaar, JW; Varmus, HE; Wellen, SL; Whitsett, JA | 1 |
| Poirier, LA; Shimkin, MB; Stoner, GD | 1 |
| Inoue, S; Ito, M; Mizuno, S; Ohnuma, T | 1 |
| Bastian, G; Demarcq, C; Remvikos, Y | 1 |
| Anisimov, VN | 1 |
| Kuwabara, H; Saito, K; Sakamoto, H; Tanaka, S; Uda, H | 1 |
| Chapman, J; Feyles, V; Jerry, LM; McGarry, RC; Tuff, A | 1 |
| Brem, SS; Brien, SE; Elkouby, MP; Gately, S; Tsanaclis, AM; Zagzag, D | 1 |
| Feyles, V; Jerry, LM; McGarry, RC; Sikora, LK | 1 |
| Cornelisse, CJ; Keijzer, R; Van de Velde, CJ; Van Dierendonck, JH | 1 |
| Muraoka, R; Shimomatsuya, T; Tanigawa, N | 1 |
| De Clercq, E; Iigo, M; Miwa, M | 1 |
| Goehde, W; Hemmer, J; Mauro, F; Salvati, F; Storniello, G; Teodori, L; Trinca, ML | 1 |
| Barlogie, B; Kute, TE; McGuire, Wl; Meyer, JS | 1 |
| Hayata, Y; Morinaga, S; Shimosato, Y; Yoshida, K | 1 |
| Fujikane, T; Ishida, S; Ohsaki, Y; Onodera, S; Shimizu, T; Tsuji, T | 1 |
| Blijham, GH; Bosman, FT; Reijnders, MM; Schutte, B; ten Velde, GP | 1 |
| Asamura, H; Shimosato, Y; Yoshida, K | 1 |
| Asamura, H; Mukai, K; Nakajima, T; Noguchi, M; Shimosato, Y; Yoshida, K | 1 |
| Dufresne, MJ; Manjunath, GS | 1 |
| Ames, RS; Carney, DN; Funkhouser, WK; Neckers, LM; Roth, JA | 1 |
| Fujikane, T; Shimizu, T | 1 |
| Kodama, T; Sato, Y; Shimosato, Y; Tada, T; Watanabe, S | 1 |
| Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Mizuno, S | 1 |
| Carmichael, J; DeGraff, WG; Gazdar, AF; Minna, JD; Mitchell, JB | 1 |
| Bagshaw, MA; Donaldson, SS; Goffinet, DR; Kaplan, HS; Martinez, A | 1 |
| Clarkson, BD; Duschinsky, R; Keller, O; Krakoff, IH; La Sala, E; Van Dyk, JJ | 1 |
| Zeidman, I | 1 |
| Takakura, K | 1 |
2 review(s) available for bromodeoxyuridine and Lung Neoplasms
| Article | Year |
|---|---|
[Analyses of cell cycle and DNA].
Topics: Adaptor Proteins, Signal Transducing; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; DNA; GRB2 Adaptor Protein; Humans; Lung Neoplasms; Microtubules; Mitogen-Activated Protein Kinases; Prognosis; Proteins; ras Proteins | 2001 |
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
1 trial(s) available for bromodeoxyuridine and Lung Neoplasms
| Article | Year |
|---|---|
Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
Topics: Adult; Aged; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Humans; Lung Neoplasms; Middle Aged; Nucleolus Organizer Region; Ploidies; S Phase; Silver Staining | 1996 |
87 other study(ies) available for bromodeoxyuridine and Lung Neoplasms
| Article | Year |
|---|---|
Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracils.
Topics: Animals; Biological Transport; Bromine Radioisotopes; Chemical Phenomena; Chemistry; DNA; Female; Floxuridine; Iodine Radioisotopes; Isotope Labeling; Lung Neoplasms; Mice; Molecular Structure; Structure-Activity Relationship; Tissue Distribution | 1989 |
SH005S7 Overcomes Primary and Acquired Resistance of Non-Small Cell Lung Cancer by Combined MET/EGFR/HER3 Inhibition.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Ki-67 Antigen; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Quinazolines; Tumor Necrosis Factor-alpha; Vimentin | 2022 |
Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‑mutated lung cancer cells.
Topics: Agar; Bromodeoxyuridine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Glutathione Peroxidase; Humans; Lung; Lung Neoplasms; Matrix Metalloproteinase 1; MicroRNAs; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species | 2022 |
Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; ErbB Receptors; Female; HeLa Cells; Humans; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Uterine Cervical Neoplasms | 2022 |
Teroxirone motivates apoptotic death in tumorspheres of human lung cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Fluorescence; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Neoplastic Stem Cells; Spheroids, Cellular; Triazines; Tumor Stem Cell Assay | 2018 |
Staurosporine Induces the Generation of Polyploid Giant Cancer Cells in Non-Small-Cell Lung Carcinoma A549 Cells.
Topics: A549 Cells; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cell Size; Giant Cells; Humans; Lung Neoplasms; Polyploidy; Staurosporine | 2018 |
Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancer.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Fluorescent Dyes; Humans; Immunohistochemistry; Kinetics; Lung Neoplasms; Mice; Mice, Knockout; Models, Biological; Neoplasms, Experimental; Organic Chemicals; Proto-Oncogene Proteins p21(ras); Time Factors; Transplantation, Heterologous | 2013 |
Proliferation of small cell lung cancer cell line reduced by knocking-down PROX1 via shRNA in lentivirus.
Topics: Blotting, Western; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Homeodomain Proteins; Humans; Lentivirus; Lung Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Small Cell Lung Carcinoma; Transfection; Tumor Suppressor Proteins | 2013 |
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Bromodeoxyuridine; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Guanidines; Humans; In Situ Nick-End Labeling; Lung; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Survival Analysis | 2011 |
Microenvironmental modulation of asymmetric cell division in human lung cancer cells.
Topics: AC133 Antigen; Antigens, CD; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; DNA Replication; DNA, Neoplasm; Glycoproteins; Humans; Lung Neoplasms; Peptides; Tumor Cells, Cultured | 2010 |
Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Cell Hypoxia; Combined Modality Therapy; Female; Gamma Rays; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Niacinamide; Radiotherapy Dosage; Temperature; Tumor Cells, Cultured | 2010 |
Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Female; Genes, ras; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenanthrenes; Proto-Oncogene Proteins B-raf; Salvia miltiorrhiza | 2011 |
S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; bcl-X Protein; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Growth Factors; RNA, Small Interfering; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Transfection | 2011 |
Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Topics: Animals; Antineoplastic Agents; Borohydrides; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Hypoxia; Female; Hyperthermia, Induced; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Niacinamide; Radiation-Sensitizing Agents; Skin Neoplasms; Sulfhydryl Compounds; Vitamin B Complex | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Differentiation; Cell Fusion; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Green Fluorescent Proteins; Humans; Indoles; Injections, Subcutaneous; Liver Neoplasms; Luminescent Agents; Luminescent Proteins; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Red Fluorescent Protein | 2013 |
Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro.
Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Survival; DNA, Neoplasm; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Purine Nucleosides; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Cells, Cultured | 2002 |
Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Disease Progression; DNA Replication; Female; Histocompatibility Testing; HLA Antigens; Humans; Immunoenzyme Techniques; In Situ Hybridization; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages, Alveolar; Male; Middle Aged; Neoplasm Staging | 2002 |
Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines.
Topics: Bromodeoxyuridine; Cell Differentiation; Epithelium; Eukaryotic Initiation Factor-4E; Humans; Keratin-8; Keratins; Lung Neoplasms | 2003 |
The mouse rasH2/BHT model as an in vivo rapid assay for lung carcinogens.
Topics: Animals; Bromodeoxyuridine; Butylated Hydroxytoluene; Carcinogenicity Tests; Carcinogens; Dose-Response Relationship, Drug; Female; Genes, ras; Immunohistochemistry; Kinetics; Lung; Lung Neoplasms; Male; Mice; Mice, Transgenic; Oncogene Protein p21(ras); Time Factors | 2002 |
Participation of kin17 protein in replication factories and in other DNA transactions mediated by high molecular weight nuclear complexes.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Colonic Neoplasms; DNA Replication; DNA-Binding Proteins; Flow Cytometry; Humans; Hydroxyurea; Lung Neoplasms; Microscopy, Immunoelectron; Mimosine; Nuclear Proteins; RNA-Binding Proteins; Tumor Cells, Cultured; Zinc Fingers | 2003 |
An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation.
Topics: Automation; Bromodeoxyuridine; Carcinoma; Cell Division; Enzyme-Linked Immunosorbent Assay; Fluorescence; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Melanoma; Neoplasm Proteins; Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 2004 |
JNK regulates autocrine expression of TGF-beta1.
Topics: Activin Receptors, Type I; Animals; Autocrine Communication; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Movement; Electrophoretic Mobility Shift Assay; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Genes, Dominant; Homozygote; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Male; Mice; Mice, Knockout; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Receptor Cross-Talk; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2004 |
In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Humans; Immunoblotting; Lung Neoplasms; Male; Phosphorylcholine; Prostatic Neoplasms; Signal Transduction; Staurosporine; Time Factors | 2004 |
The gap junction protein connexin32 is a mouse lung tumor suppressor.
Topics: Animals; Bromodeoxyuridine; Connexins; Diethylnitrosamine; Disease Models, Animal; Enzyme Activation; Female; Gap Junction beta-1 Protein; Gap Junctions; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptides; Pulmonary Surfactant-Associated Protein C | 2004 |
Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.
Topics: Apoptosis; Bromodeoxyuridine; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Humans; Lung Neoplasms; Polo-Like Kinase 1; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Antisense; Transfection; Vinblastine; Vinorelbine | 2004 |
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Suramin; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2005 |
Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Blotting, Western; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Cricetinae; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation, Neoplastic; Humans; Isoproterenol; Lung Neoplasms; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Signal Transduction | 2005 |
Lung as a new target in rats of 2-amino-3-methylimidazo[4,5-f]quinoline carcinogenesis: results of a two-stage model initiated with N-bis(2-hydroxypropyl)nitrosamine.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Bromodeoxyuridine; Carcinogens; Cell Proliferation; Disease Models, Animal; DNA; DNA Damage; Guanine; Lipid Peroxidation; Lung; Lung Neoplasms; Male; Nitrosamines; Oxidative Stress; Quinolines; Rats; Thiobarbituric Acid Reactive Substances | 2006 |
5-Bromodeoxyuridine induced differentiation of a human small cell lung cancer cell line is associated with alteration of gene expression.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Differentiation; Cell Line, Tumor; Connexin 26; Connexins; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Genes, Homeobox; Homeodomain Proteins; Humans; Insulin-Like Growth Factor Binding Proteins; Lung Neoplasms; Mice; Neoplasm Transplantation; Paired Box Transcription Factors; Pulmonary Surfactant-Associated Protein C; Transcription Factors; Up-Regulation | 2007 |
Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer.
Topics: Base Sequence; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cell Division; DNA Primers; Gene Silencing; Genes, Homeobox; Homeodomain Proteins; Humans; Hydroxamic Acids; Loss of Heterozygosity; Lung Neoplasms; RNA, Small Interfering | 2007 |
5-Bromo-2-deoxyuridine activates DNA damage signalling responses and induces a senescence-like phenotype in p16-null lung cancer cells.
Topics: Antimetabolites, Antineoplastic; beta-Galactosidase; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; DNA Damage; DNA, Neoplasm; Humans; Lung Neoplasms | 2007 |
Puma is a novel target of soy isoflavone genistein but is dispensable for genistein-induced cell fate determination.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Bromodeoxyuridine; Caspase 3; Cell Division; Cell Line; Cell Line, Tumor; Genistein; HeLa Cells; Humans; Isoflavones; Lung Neoplasms; Proto-Oncogene Proteins; RNA Interference; RNA, Small Interfering; Tetrazolium Salts | 2008 |
Short- and long-term studies on chemical carcinogenesis in BALB/Mo mice.
Topics: Adenoma; Animals; Animals, Newborn; Bromodeoxyuridine; Cocarcinogenesis; Deoxyadenosines; Female; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred BALB C; Moloney murine leukemia virus; Oncogenes; Pregnancy; Prenatal Exposure Delayed Effects; Sister Chromatid Exchange; T-Lymphocytes; Urethane | 1984 |
Unequal forms of 140-110 kD glycoproteins in B16 melanoma cells with differing detachment properties and metastatic behavior: influence of bromodeoxyuridine.
Topics: Animals; Bromodeoxyuridine; Cell Aggregation; Cell Line; Culture Media; Electrophoresis, Polyacrylamide Gel; Glycoproteins; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Molecular Weight; Neoplasm Proteins; Precipitin Tests | 1984 |
Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
Topics: Biopsy; Bromodeoxyuridine; Cell Division; DNA; Female; Flow Cytometry; Humans; Immunohistochemistry; Infant, Newborn; Ki-67 Antigen; Lung Neoplasms; Male; Neoplasm Proteins; Nuclear Proteins; Ploidies; Proliferating Cell Nuclear Antigen | 1995 |
Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
Topics: Adenocarcinoma; Adult; Aged; Base Sequence; Blotting, Western; Bromodeoxyuridine; Bronchi; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Chemotaxis; DNA Primers; Epithelial Cells; Epithelium; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Lung Diseases; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Molecular Sequence Data; Neoplasm Invasiveness; Polymerase Chain Reaction; Proto-Oncogene Proteins c-met; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Tumor Cells, Cultured | 1995 |
S-phase arrest of nutrient deprived lung cancer cells.
Topics: Bromodeoxyuridine; Carcinoma, Small Cell; Cell Division; Culture Media; DNA, Neoplasm; Flow Cytometry; Humans; Ki-67 Antigen; Kinetics; Lung Neoplasms; Neoplasm Proteins; Nuclear Proteins; Proliferating Cell Nuclear Antigen; S Phase; Tumor Cells, Cultured | 1995 |
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Topics: Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Flow Cytometry; G1 Phase; Genes, p53; Humans; Kinetics; Lung Neoplasms; Mutation; S Phase; Tumor Cells, Cultured | 1994 |
Importance of species differences in experimental pulmonary carcinogenicity of inhaled cadmium for extrapolation to humans.
Topics: Administration, Inhalation; Animals; Bromodeoxyuridine; Cadmium; Disease Models, Animal; Humans; Lung; Lung Neoplasms; Male; Metallothionein; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Species Specificity; Time Factors | 1994 |
In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Neoplasms | 1994 |
Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors.
Topics: Antibodies, Monoclonal; Antigens; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Humans; Ki-67 Antigen; Lung Neoplasms; Neoplasm Proteins; Nuclear Proteins | 1993 |
Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.
Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Bromodeoxyuridine; Bronchoscopy; Cell Cycle; Cell Division; Diploidy; DNA, Neoplasm; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; S Phase | 1993 |
Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Topics: Animals; Base Sequence; Bromodeoxyuridine; Carcinogens; Cell Division; Female; Genes, ras; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Inbred A; Molecular Sequence Data; Nitrosamines; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 1996 |
Tumour cell kinetics as prognostic factor in surgically-treated-non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Humans; Lung Neoplasms; Middle Aged; Prognosis; S Phase; Survival Rate | 1997 |
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured | 1997 |
Regression of pulmonary lesions produced by inhaled titanium dioxide in rats.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Collagen; Fibroblasts; Immunohistochemistry; Lung Neoplasms; Macrophages; Male; Particle Size; Proliferating Cell Nuclear Antigen; Pulmonary Alveoli; Rats; Rats, Inbred F344; Time Factors; Titanium | 1997 |
Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice.
Topics: Animals; Antineoplastic Agents; Biflavonoids; Body Weight; Bromodeoxyuridine; Carcinogens; Catechin; Cell Division; Chemoprevention; Female; Hyperplasia; Lung Neoplasms; Mice; Mice, Inbred A; Nitrosamines; Tea; Vitamin A; Vitamin E | 1997 |
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured | 1998 |
Ki-67 (MIB 5) immunostaining of mouse lung tumors induced by 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Adenocarcinoma; Adenoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinogens; Cell Count; Cell Division; Immunoenzyme Techniques; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Inbred A; Recombinant Proteins | 1998 |
Bromodeoxyuridine induces keratin protein synthesis at a posttranscriptional level in human lung tumour cell lines.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Small Cell; Down-Regulation; Humans; Keratins; Lung Neoplasms; Protein Processing, Post-Translational; RNA, Messenger; Tumor Cells, Cultured | 1999 |
Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients.
Topics: Adult; Aged; Antigens, CD34; Apoptosis; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; Drug Therapy, Combination; Erythropoietin; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukocyte Count; Lung Neoplasms; Middle Aged; Platelet Count; Recombinant Proteins; Time Factors; Topotecan | 1999 |
Overexpression of kin17 protein disrupts nuclear morphology and inhibits the growth of mammalian cells.
Topics: Animals; Antigens, Polyomavirus Transforming; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Nucleus; Chromatin; DNA Replication; DNA-Binding Proteins; DNA, Complementary; Extrachromosomal Inheritance; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Dominant; HeLa Cells; Humans; Lung Neoplasms; Mammals; Mutagenesis; Nuclear Proteins; Nucleic Acid Conformation; Rec A Recombinases; RNA-Binding Proteins; S Phase; Zinc Fingers | 1999 |
[Search for Ki-ras codon 61 mutations in lung adenomas induced in neonatal BALB/c mice with 5-bromodesoxyuridine injection followed by urethane treatment].
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Codon; Disease Models, Animal; DNA, Neoplasm; Female; Genes, ras; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Urethane | 1999 |
Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Topics: Binding Sites; Bromodeoxyuridine; Cell Division; DNA-Binding Proteins; DNA, Recombinant; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Plasmids; Protein Structure, Tertiary; Receptors, Retinoic Acid; Response Elements; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Tumor Cells, Cultured | 2001 |
Assay for DNA damage using immunochemical recognition and capillary electrophoresis.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; DNA Adducts; DNA Damage; DNA, Neoplasm; Electrophoresis, Capillary; Immunochemistry; Immunoglobulin G; Lung Neoplasms; Mice; Microscopy, Fluorescence; Plasmids; Sensitivity and Specificity; Skin; Tumor Cells, Cultured | 2001 |
Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.
Topics: Blotting, Northern; Bromodeoxyuridine; Gene Expression; HL-60 Cells; Humans; Immunohistochemistry; Keratins; Lung Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Topics: Adenocarcinoma; Adenoma; Animals; Apoptosis; Bromodeoxyuridine; Cyclin-Dependent Kinase Inhibitor p16; DNA Primers; Gene Expression Regulation, Neoplastic; Genes, ras; Genes, Tumor Suppressor; Genotype; In Situ Nick-End Labeling; Lung Neoplasms; Mice; Mice, Knockout; Mice, Transgenic; Models, Genetic; Neoplasm Recurrence, Local; Reverse Transcriptase Polymerase Chain Reaction; Tetracycline; Transgenes; Tumor Suppressor Protein p53 | 2001 |
Bromodeoxyuridine induces integrin expression at transcriptional (alpha2 subunit) and post-transcriptional (beta1 subunit) levels, and alters the adhesive properties of two human lung tumour cell lines.
Topics: Antigens, CD; Antimetabolites, Antineoplastic; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Extracellular Matrix; HL-60 Cells; Humans; Immunohistochemistry; Integrin alpha2; Integrin beta1; Integrins; Lung Neoplasms; Precipitin Tests; Protein Biosynthesis; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation | 2001 |
Bioassay of alkyl halides and nucleotide base analogs by pulmonary tumor response in strain A mice.
Topics: Adenoma; Alkanes; Animals; Biological Assay; Bromodeoxyuridine; Carcinogens; Deoxyuridine; Female; Floxuridine; Halogens; Idoxuridine; Lung Neoplasms; Male; Mice; Mice, Inbred A; Neoplasms, Experimental | 1975 |
Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carboplatin; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Interactions; Flow Cytometry; Humans; Ki-67 Antigen; Kinetics; Lung Neoplasms; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Rhodamine 123; Rhodamines; Subcellular Fractions; Time Factors; Tumor Cells, Cultured | 1992 |
BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA Damage; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Lung Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Two-step carcinogenesis induced by neonatal exposure to 5-bromo-2'- deoxyuridine and subsequent administration of urethan in BALB/c mice.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Body Weight; Bromodeoxyuridine; Cocarcinogenesis; Female; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size; Urethane | 1992 |
A light and electron microscopic histochemical study on lectin binding to cells with high metastatic potential in Lewis lung carcinoma.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cell Transformation, Neoplastic; Concanavalin A; Histocytochemistry; Immunohistochemistry; Lectins; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neoplasm Metastasis; Neoplasms, Experimental; Peanut Agglutinin; Plant Lectins; Tumor Cells, Cultured | 1992 |
Induced morphological changes in human small cell lung carcinoma cells.
Topics: Bromodeoxyuridine; Carcinoma, Small Cell; Cell Adhesion; Cell Aggregation; Gene Expression; Genes, myc; Humans; Lung Neoplasms; Phenotype; Tumor Cells, Cultured | 1991 |
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Capillary Permeability; Cell Division; Copper; Diet; Fibronectins; Glioma; Lung Neoplasms; Neovascularization, Pathologic; Penicillamine; Rabbits; Rats | 1990 |
Effects of retinoic acid and bromodeoxyuridine on human melanoma-associated antigen expression in small cell lung carcinoma cells.
Topics: Antigens, Neoplasm; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Adhesion; Flow Cytometry; Humans; Lung Neoplasms; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Precipitin Tests; Tretinoin; Tumor Cells, Cultured | 1991 |
Surgically induced cytokinetic responses in experimental rat mammary tumor models.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Disease Models, Animal; Female; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Regression Analysis; Tumor Cells, Cultured | 1991 |
Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Colonic Neoplasms; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Ploidies; Rectal Neoplasms; Stomach Neoplasms; Transplantation, Heterologous | 1991 |
Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antiviral Agents; Bromodeoxyuridine; Colonic Neoplasms; Drug Therapy, Combination; Floxuridine; Fluorouracil; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pentosyltransferases; Prodrugs; Pyrimidine Phosphorylases | 1990 |
Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |
Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.
Topics: Analysis of Variance; Aneuploidy; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; Cell Line; DNA; Female; Flow Cytometry; Humans; Interphase; Lung Neoplasms; Lymph Nodes; Multiple Myeloma; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; RNA; Thymidine | 1985 |
A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Cell Nucleus; Female; Humans; Immunoenzyme Techniques; Kinetics; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitotic Index | 1989 |
Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cisplatin; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Lung Neoplasms; Tumor Cells, Cultured | 1989 |
Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
Topics: Bromodeoxyuridine; Bronchoscopy; Cell Cycle; Cell Transformation, Neoplastic; DNA, Neoplasm; Flow Cytometry; Humans; Lung Neoplasms | 1989 |
[The degree of malignancy in lung adenocarcinoma and related factors-- nuclear DNA content and bromodeoxyuridine labeling index].
Topics: Adenocarcinoma; Aneuploidy; Bromodeoxyuridine; Cell Differentiation; Cell Nucleus; DNA, Neoplasm; Humans; Lung Neoplasms; Neoplastic Stem Cells; Prognosis; Prospective Studies | 1989 |
Factors possibly affecting the degree of malignancy in adenocarcinoma of the lung. DNA content and bromodeoxyuridine (BrdU) labeling index.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Humans; Lung Neoplasms; Prognosis | 1989 |
Plasmid DNA mediated transfer of the herpes simplex virus thymidine kinase gene to a new bromodeoxyuridine resistant variant of human primary lung carcinoma cells.
Topics: Bromodeoxyuridine; Drug Resistance; Humans; In Vitro Techniques; Lung Neoplasms; Mutation; Plasmids; Simplexvirus; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1988 |
Inhibition of DNA synthesis by a small-cell lung carcinoma-derived protein.
Topics: Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; Cell Line; Chemical Phenomena; Chemistry, Physical; DNA; Humans; Kinetics; Lung Neoplasms; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Trypsin | 1986 |
[Studies on cell cycle analysis using a monoclonal antibody to bromodeoxyuridine (BrdU labeling method)].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; Cisplatin; DNA, Neoplasm; Humans; In Vitro Techniques; Lung Neoplasms; Vindesine | 1988 |
Immunohistochemical cell kinetic study of human lung cancer by using monoclonal antibody to bromodeoxyuridine.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Histocytochemistry; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitotic Index; Thymidine; Tritium | 1986 |
[Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; DNA, Neoplasm; Flow Cytometry; Humans; Lung Neoplasms | 1986 |
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.
Topics: Animals; Autoanalysis; Bromodeoxyuridine; Cell Line; Clone Cells; Colorimetry; Coloring Agents; Cricetinae; Cricetulus; Cysteamine; Humans; Lung Neoplasms; Radiation-Sensitizing Agents; Tetrazolium Salts; Thiazoles; Time Factors | 1987 |
Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Combined Modality Therapy; Follow-Up Studies; Hand Dermatoses; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Osteosarcoma; Pubic Bone; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1985 |
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Animals; Bromodeoxyuridine; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Colonic Neoplasms; Deoxyuridine; Dogs; Female; Floxuridine; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Ileocecal Valve; Intestinal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Rectal Neoplasms; Sarcoma; Stomach Neoplasms | 1967 |
Effect of 5-bromodeoxyuridine (BUdR) on experimental metastasis.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Clone Cells; Dose-Response Relationship, Drug; Idoxuridine; Lung Neoplasms; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Thymidine; Time Factors | 1973 |
[Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Radiation-Sensitizing Agents | 1971 |